Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Dolby Laboratories (DLB) - free report >>
HOOKIPA Pharma Inc. (HOOK) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Dolby Laboratories (DLB) - free report >>
HOOKIPA Pharma Inc. (HOOK) - free report >>
Image: Bigstock
New Strong Sell Stocks for November 18th
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Amyris, Inc. is a biotechnology company. The Zacks Consensus Estimate for its current year earnings has been revised 29.3% downward over the last 30 days.
ThermoGenesis Holdings, Inc. (THMO - Free Report) is a developer and marketer of automated technologies for chimeric antigen receptor (CAR)-T and other cell-based therapies. The Zacks Consensus Estimate for its current year earnings has been revised 42.4% downward over the last 30 days.
Cogent Biosciences, Inc. (COGT - Free Report) is engaged in developing a pipeline of novel therapies to treat cancer patients. The Zacks Consensus Estimate for its current year earnings has been revised more than 100% downward over the last 30 days.
Dolby Laboratories, Inc. (DLB - Free Report) is a creator of audio and imaging technologies. The Zacks Consensus Estimate for its current year earnings has been revised 1.6% downward over the last 30 days.
HOOKIPA Pharma Inc. (HOOK - Free Report) is a clinical stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 16.1% downward over the last 30 days.
View the entire Zacks Rank #5 List.